Prevalence, awareness, treatment, and control of hypertension among residents in Guangdong Province, China, 2004 to 2007

Circulation: Cardiovascular Quality and Outcomes

Volumn 6, Issue 2, 2013, Pages 217-222

  Xu, Bayi ^a   Xu, Zhixia ^a   Xu, Xiaojun ^b   Cai, Qiumao ^b   Xu, Yanjun ^b  

^a Department of Noncommunicable Disease Control and Prevention   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Hypertension; Prevalence; Prevention; Surveillance; Trends

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CARDIOVASCULAR RISK; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; AWARENESS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877933159     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.111.000062     Document Type: Article

References (31)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
2. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-1134.
3. Whitworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
4. Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2010;55:590-598.
5. Kwan TW, Yu C, Zheng YX, Kwan J, Stein RA, Chen SL, Hu DY. Hypertension in China: past, present, and future. Curr Hypertens Rev. 2008;4:241-244.
6. Zhong GF, Xiang YZ. China's research progress of hypertension epidemiology and impact factors. Chin J Public Health. 2010;26:301-302.
7. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, Woodward M, Li X, Chalmers J, Gao R, Kong L, Yang X; China NNHS Steering Committee; China NNHS Working Group. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008;118:2679-2686.
8. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
9. Wang LD. Nutrition and Health Status in Chinese People. Beijing, China: People's Publishing House; 2005.
10. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, Duan X, Whelton PK, He J; InterASIA Collaborative Group. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21:1273-1281.
11. The Sixth National Census Bulletin. National Bureau of Statistics of the People's Republic of China. 2011. http://www.stats.gov.cn/. Accessed March 6, 2013.
12. Ma WJ, Nie SP, Xu YJ, Xu HF, Li JS, Li HK, Fu CX, Chen ZC, Lin JY. Risk factors related to hypertension in Guangdong Province. South China J Prev Med. 2003;29:25-27.
13. Yang G, Hu J, Rao KQ, Ma J, Rao C, Lopez AD. Mortality registration and surveillance in China: history, current situation and challenges. Popul Health Metr. 2005;3:3.
14. - 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension: Guidelines Subcommittee. J Hypertens. 1999;17:151-183.
15. Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension. Chinese guidelines for prevention and treatment of patients with hypertension. Chin J Hypertens. 2005;134:2-41.
16. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157:2413-2446.
17. Zhou B. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23:5-10.
18. WHO Expert Committee. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
19. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
20. Rao XX, Cen RC, Mai JZ. Recent trend of hypertension in Guangdong Province. South China J Cardiol. 1996;2:1-3.
21. Ma WJ, Xu YJ, Xu HF, Nie SP, Li JS, Fu CX, Chen MF, Lin JY, Chen ZC. Analysis on epidemiological characteristics and control effect of hypertension in Guangdong. South China J Prev Med. 2003;29:20-24.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
23. Natali A, Muscelli E, Casolaro A, Nilsson P, Melander O, Lalic N, Ferrannini E, Petrie JR. Metabolic characteristics of prehypertension: role of classification criteria and gender. J Hypertens. 2009;27:2394-2402.
24. Gu D, Chen J, Wu X, Duan X, Jones DW, Huang JF, Chen CS, Chen JC, Kelly TN, Whelton PK, He J. Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens. 2009;27:721-729.
25. Yu D, Huang J, Hu D, Chen J, Cao J, Li J, Gu D. Association between prehypertension and clustering of cardiovascular disease risk factors among Chinese adults. J Cardiovasc Pharmacol. 2009;53:388-400.
26. Kawamoto R, Kohara K, Tabara Y, Abe M, Kusunoki T, Miki T. Insulin resistance and prevalence of prehypertension and hypertension among community-dwelling persons. J Atheroscler Thromb. 2010;17:148-155.
27. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, He J. Factors associated with hypertension awareness, treatment, and control in a representative sample of the chinese population. Hypertension. 2004;43:578-585.
28. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
29. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, Wang W, Li Y. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J. 1995;108:483-489.
30. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J; InterASIA Collaborative Group. The International Collaborative Study of Cardiovascular Disease in Asia: prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40:920-927.
31. Dong GH, Sun ZQ, Zhang XZ, Li JJ, Zheng LQ, Li J, Hu DY, Sun YX. Prevalence, awareness, treatment & control of hypertension in rural Liaoning province, China. Indian J Med Res. 2008;128:122-127.